Recently, the intracerebroventicular infusion of neutralizing anti-IFNγ antibody has been shown to delay the motor function decline in SOD1G93A mice, suggesting that IFNγ contributes to ALS pathogenesis (Otsmane et al., 2013). Here, IFNG is linked to amyotrophic lateral sclerosis.